141 related articles for article (PubMed ID: 22296769)
1. MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.
Kaitu'u-Lino TJ; Palmer KR; Whitehead CL; Williams E; Lappas M; Tong S
Am J Pathol; 2012 Mar; 180(3):888-894. PubMed ID: 22296769
[TBL] [Abstract][Full Text] [Related]
2. MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production.
Kaitu'u-Lino TJ; Tuohey L; Ye L; Palmer K; Skubisz M; Tong S
Placenta; 2013 Feb; 34(2):168-73. PubMed ID: 23261267
[TBL] [Abstract][Full Text] [Related]
3. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14.
Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S
Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228
[TBL] [Abstract][Full Text] [Related]
4. MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin.
Kaitu'u-Lino TJ; Palmer K; Tuohey L; Ye L; Tong S
PLoS One; 2012; 7(6):e39864. PubMed ID: 22768148
[TBL] [Abstract][Full Text] [Related]
5. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
6. MMP-14 aggravates onset of severe preeclampsia by mediating soluble endoglin release.
Zhang XH; Zhang HY; Lu S; Jiang LL; Wu J; Yang YL; Zhang SA
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1209-1215. PubMed ID: 29565476
[TBL] [Abstract][Full Text] [Related]
7. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
[TBL] [Abstract][Full Text] [Related]
8. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis.
Hawinkels LJ; Kuiper P; Wiercinska E; Verspaget HW; Liu Z; Pardali E; Sier CF; ten Dijke P
Cancer Res; 2010 May; 70(10):4141-50. PubMed ID: 20424116
[TBL] [Abstract][Full Text] [Related]
10. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
[TBL] [Abstract][Full Text] [Related]
11. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
[TBL] [Abstract][Full Text] [Related]
12. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells.
Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ
J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845
[TBL] [Abstract][Full Text] [Related]
13. Oxysterol-induced soluble endoglin release and its involvement in hypertension.
Valbuena-Diez AC; Blanco FJ; Oujo B; Langa C; Gonzalez-Nuñez M; Llano E; Pendas AM; Díaz M; Castrillo A; Lopez-Novoa JM; Bernabeu C
Circulation; 2012 Nov; 126(22):2612-24. PubMed ID: 23110859
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
[TBL] [Abstract][Full Text] [Related]
16. Soluble endoglin contributes to the pathogenesis of preeclampsia.
Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
[TBL] [Abstract][Full Text] [Related]
17. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
18. Expression of antiangiogenic factors in the placental structures in pre-eclampsia.
Shchyogolev AI; Dubova EA; Pavlova KA; Lyapin VM; Sukhikh GT
Bull Exp Biol Med; 2012 Dec; 154(2):287-91. PubMed ID: 23330145
[TBL] [Abstract][Full Text] [Related]
19. TREM-1 expression is increased in human placentas from severe early-onset preeclamptic pregnancies where it may be involved in syncytialization.
Lim R; Barker G; Lappas M
Reprod Sci; 2014 May; 21(5):562-72. PubMed ID: 24026310
[TBL] [Abstract][Full Text] [Related]
20. Membrane and soluble forms of endoglin in preeclampsia.
Oujo B; Perez-Barriocanal F; Bernabeu C; Lopez-Novoa JM
Curr Mol Med; 2013 Sep; 13(8):1345-57. PubMed ID: 23826920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
